Company intelligence
Evidencia Scientific Search and Selection Limited
About Evidencia Scientific Search and Selection Limited
Evidencia Scientific Search and Selection - Global Provider of Recruitment Solutions to the Pharmaceutical Industry across Late Phase Commercialisation With specialist staffing expertise across Late Phase Pharmaceutical Drug Commercialisation, Evidencia recruits in the following areas for Consulting, Pharma, Biotech and Medical Device Companies: Market Access Operational and Strategic Pricing and Reimbursement Health Economics and Outcomes Research Real World Evidence Commercialisation Strategy The focus of Evidencia’s work is on Pains and Issues experienced by both Clients and Candidates, and Results and Opportunities that both parties might look to uncover and achieve. Companies turn to us when they need to hire talent in the Commercialisation space because: • Critical product launches are coming up, and it is imperative that the product passes the HTA submission and is launched successfully • Their current team is stretched, causing project slippage, lost revenue and Clients, and a frustrated team who are feeling overworked • They wish to generate significant growth in revenues, turnover and company size • There is a desire to expand in to new markets, either through geographies, deliverables or new disease areas • A new team structure or division is to be built • Market insights in terms of what the talent pool is like, salary benchmarking • Development of their company value story to attract and retain staff Candidates approach Evidencia for support because: • They wish to gain progression in to new areas, career levels or skill sets • They wish to understand what career paths they should take to reach their ultimate career goals • The training and development opportunities where they are currently are not as strong as they could be • There is a desire to transition from Consulting to Pharma Evidencia Scientific has 20 years experience in supporting Companies and Candidates in the Life Science arena in the Late Phase Commercialisation niche.
Verified activity
Signals from Evidencia Scientific Search and Selection Limited
10 published signals
People
Evidencia Scientific Search and Selection Limited completed two US leadership searches in Q3.
Reported by Greg Harris
People
Evidencia Scientific Search and Selection Limited is hiring a new Consultant for Life Sciences Consulting in London, United Kingdom, with a hybrid work model.
Reported by Evidencia Scientific Search and Selection Limited
People
Evidencia Scientific Search and Selection Limited is hiring a new Freelance Director Business Development - Market Access & Life Sciences in the United States.
Reported by Evidencia Scientific Search and Selection Limited
People
Evidencia Scientific Search and Selection Limited is hiring a new Engagement Manager in New York.
Reported by Evidencia Scientific Search and Selection Limited
People
Evidencia Scientific Search and Selection Limited is hiring a Principal Consultant for Evidence Synthesis based in the UK or Europe.
Reported by Greg Harris
People
Evidencia Scientific Search and Selection Limited is hiring a new SLR/Evidence Synthesis Lead for a full remote flexibility role in the Global HEOR Consulting firm in the United Kingdom.
Reported by Evidencia Scientific Search and Selection Limited
People
Evidencia Scientific Search and Selection Limited is hiring a remote-based Principal-level Evidence Synthesis expert for a fast-growing specialist HEOR consultancy expanding its senior evidence synthesis capability.
Reported by Greg Harris
People
Evidencia Scientific Search and Selection Limited is working with a global healthcare consultancy to bring in a senior Health Economist or HEOR leader to build and shape a growing practice.
Reported by Greg Harris
People
Evidencia Scientific Search and Selection Limited is hiring a Competitive Intelligence Consultant for Life Sciences Strategy in London on a hybrid model.
Reported by Greg Harris
People
Evidencia Scientific Search and Selection Limited is hiring a Principal-level Evidence Synthesis expert based in the UK or Europe to lead complex SLR, NMA, meta-analysis, and indirect treatment comparison projects across HTA, payer engagement, and market access.
Reported by Greg Harris